Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hospital-based Cause Of Death Notification System

A National Hospital Based Mortality Notification system (HMS) was established at the beginning of 2017 in collaboration with the World Health Organization and in cooperation with the Syndicate of hospitals as an expansion of the maternal and neonatal death reporting system established in 2011. The system consists of anonymous online reporting of deaths based on an excerpt of the official death certificate form. Focal points were assigned and trained in more than 150 public and private hospitals operating in Lebanon. After reporting the information, quality checks are initiated through constant communication between the statistics department and the hospitals’ focal points. After that, the underlying cause of death is selected from the reported causes of the death.
 
 
Hospital Mortality Statistics 2025
Hospital Deaths due to COVID-19 by Week, 2020-2025 (till August 2025)​


Hospital Deaths due to COVID-19 by Month, 2020-2025 (till August 2025)​
 
 
Hospital Mortality Statistics 2024
Number of reported hospital deaths and proportional mortality due to malignant neoplasms, 2017-2024

Top Cancer Killers In Men and Women,2024
 
Hospital Mortality Statistics 2022
Top Cancer Killers in Men and Women, 2022
 
Hospital Mortality Statistics 2021
Number of reported Lebanese hospital deaths by month and age group


Number of reported hospital deaths by month and age group in Lebanon



Number of reported COVID-19 hospital deaths by month and age group


Weekly Total Hospital Deaths and COVID19 Related Deaths

 
Hospital Mortality Statistics 2020 and 2021
Weekly Total Hospital Deaths and COVID19 Related Deaths 2020​​&2021

 

 
Hospital Mortality Statistics 2020
Number of reported Lebanese hospital deaths by month and age group

Number of reported hospital deaths by month and age group in Lebanon

Number of reported COVID-19 hospital deaths by month and age group in Lebanon

Weekly Total Hospital Deaths and COVID19 Related Deaths

 
Hospital Mortality Statistics 2019
Number of reported Lebanese hospital deaths by month and age group, 2019

Number of reported hospital deaths by month and age group in Lebanon, 2019 (Updated)​
 
 
Hospital Mortality Statistics 2018
Number of reported Lebanese hospital deaths by month and age group, 2018


Number of reported hospital deaths by month and age group in Lebanon, 2018 ​
 
Hospital Mortality Statistics 2017
Number of reported Lebanese hospital deaths by month and age group, 2017


Number of reported hospital deaths by month and age group in Lebanon, 2017

Reported hospital deaths by top ICD10 chapters, 2017  
 


Top 10 cancers by ICD10 3-character code, 2017​
 


Plot of the number of the reported deaths by size and type of hospital, 2017



Five leading cancer deaths by gender, 2017
 


Top 10 leading causes of reported hospital deaths by ICD10 4-character code and gender, 2017
 
 

Proportion of reported hospital deaths by age group and gender in Lebanon, 2017 

 
 
    1
ATC ↑ Name B/G Ingredients Dosage Form Price
A02BC01 NEOOPRAZOLE G Omeprazole - 20mg 20mg Capsule, hard, gastro-resistant 407,184 L.L
A02BC05 NEXIUM B Esomeprazole (magnesium trihydrate) - 20mg 20mg Tablet, gastroresistant 1,005,194 L.L
A02BC05 NEXIUM B Esomeprazole (magnesium trihydrate) - 20mg 20mg Tablet, gastroresistant 1,005,194 L.L
A02BC05 NEXPRAZOL 20 G Esomeprazole - 20mg 20mg Tablet, enteric coated 275,168 L.L
A02BC05 NEXIUM B Esomeprazole (magnesium trihydrate) - 40mg 40mg Tablet, enteric coated 1,138,235 L.L
A02BC05 NEXIUM B Esomeprazole (magnesium trihydrate) - 40mg 40mg Tablet, enteric coated 1,138,235 L.L
A02BC05 NEXIUM B Esomeprazole sodium - 40mg 40mg Injectable powder for solution 5,254,424 L.L
A02BC05 NEXIUM B Esomeprazole (magnesium trihydrate) - 10mg 10mg Granules, gastroresistant, for suspension 1,721,462 L.L
A02BC05 NEXIUM B Esomeprazole (magnesium trihydrate) - 10mg 10mg Granules, gastroresistant, for suspension 1,721,462 L.L
A03AB06 NOSPAZM G Otilonium bromide - 40mg 40mg Tablet, film coated 282,207 L.L
A03FA03 NAUZEX G Domperidone - 10mg 10mg Tablet 258,530 L.L
A03FA03 NOVADOM G Domperidone - 10mg 10mg Tablet 278,175 L.L
A04AA01 NAUSETRON G Ondansetron (HCl dihydrate) - 8mg 8mg Tablet, scored 1,023,880 L.L
A04AA01 NOZENTRIX G Ondansetron - 8mg 8mg Tablet, film coated 1,151,865 L.L
A04AA01 NOZAMET G Ondansetron - 8mg 8mg Film, orodispersible 6,075,448 L.L
A04AA01 NAUSETRON G Ondansetron - 4mg/5ml 4mg/5ml Solution 958,608 L.L
A04AA01 NAUSETRON G Ondansetron - 4mg/5ml 4mg/5ml Solution 802,466 L.L
A04AA01 NOZAMET G Ondansetron - 4mg 4mg Film, orodispersible 3,234,181 L.L
A04AA02 NEOSET G Granisetron (HCl) - 3mg/3ml 3mg/3ml Injectable solution 405,840 L.L
A07AA11 NORMIX TAB B Rifaximin alpha - 200mg 200mg Tablet, film coated 827,807 L.L
A07AA11 NORMIX SIROP B Rifaximin alpha - 100mg/5ml 100mg/5ml Granules for suspension 477,064 L.L
A07AX03 NIFUNAL G Nifuroxazide - 200mg 200mg Capsule, hard 217,702 L.L
A10AB05 NOVORAPID FLEXPEN BioTech Insulin aspart - 100IU/ml 100IU/ml Injectable solution 3,123,090 L.L
A10AB05 NOVORAPID FLEXPEN BioTech Insulin aspart - 100IU/ml 100IU/ml Injectable solution 3,123,090 L.L
A10AB05 NOVORAPID FLEXPEN BioTech Insulin aspart - 100IU/ml 100IU/ml Injectable solution 3,123,090 L.L
A10AD05 NOVOMIX 30 BioTech Insulin aspart - 30%, Insulin aspart protamine - 70% 100IU/ml Injectable suspension 4,264,012 L.L
A10AD05 NOVOMIX 30 BioTech Insulin aspart - 30%, Insulin aspart protamine - 70% 100IU/ml Injectable suspension 4,264,012 L.L
A10AD05 NOVOMIX 30 BioTech Insulin aspart - 30%, Insulin aspart protamine - 70% 100IU/ml Injectable suspension 4,264,012 L.L
A10BX02 NOVONORM B Repaglinide - 2mg 2mg Tablet 666,546 L.L
A10BX02 NOVONORM B Repaglinide - 0.5mg 0.5mg Tablet 475,720 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2025